| Catalog: | C0630A |
| Product Type: | Antibody |
| Reactivity: | H,M |
| Analysis mode: | IHC,ELISA |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Isotype: | IgG |
| Concentration: | 0.7 mg/mL |
| Storage: | -20℃ |
| Buffer: | PBS with 0.05% sodium azide and 50% glycerol, PH7.4 |
| Purification method: | Affinity purification |
| Application: | Cancer, Epigenetics and Nuclear Signaling |
| Conjugation: | Unconjugated |
| Immunogen: | RUNX1T1 |
| Swiss port: | Q06455 |
| Gene accession: | NP001185554 |
| Celluar localization: | Nucleus |
| Tissue specificity: | It is most expressed in the brain, but lower in the lungs, heart, testes and ovaries. |
This gene encodes a member of the myeloid translocation gene family that interacts with DNA-bound transcription factors and recruits a series of co-repressor factors to promote transcriptional inhibition. t(8;21)(q22;q22) translocation is one of the most common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene, which is formed by fusing the 5'-region of the runt-related transcription factor 1 gene with the 3'-region of the gene. The chimeric protein is believed to bind to the nuclear co-inhibitor/histone deacetylase complex, thereby hindering hematopoietic differentiation.
Copyright © 2025 Creative Biogene. All rights reserved.